Aclaris Therapeutics Inc. (ACRS) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Aclaris Therapeutics Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$3.96
+4.49% today
Market cap
$558M
Overall quality
29/100
Kronos AI 30-day
+29.7%
8 of 8 simulated paths end higher
Aclaris Therapeutics Inc. (ACRS) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $558M. It trades at $3.96, up 4.49% today. Its overall quality score is 29 out of 100, ranked against the whole US market. 5 analysts' average target of $11.50 implies +190.4% from today's price. Kronos AI's 30-day forecast is +29.7% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $11.50 |
| Low – high | $9.00 – $16.00 |
| Analysts | 5 |
| Upside to average | +190.4% |
Kronos AI 30-day forecast
| Expected close | $4.92 (+29.7%) |
| Likely range | +27.2% … +44.7% |
| As of | 2026-10-27 |
8 of 8 simulated paths end higher.
Quality scores
| Profitability | 8 |
| Solvency | 54 |
| Growth | 24 |
| Overall | 29 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Halal Health Care stocks · Zakat calculator · Purification calculator
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.